|
Volumn 42, Issue 2, 2008, Pages 107-113
|
Sample size requirements for clinical trials with repeated binary outcomes
|
Author keywords
Compound symmetry; Dropout; GEE; Independent missing; Monotone missing
|
Indexed keywords
ANTIFIBROTIC AGENT;
NEUROLEPTIC AGENT;
PLACEBO;
ARTICLE;
CLINICAL TRIAL;
COMPUTER PROGRAM;
CORRELATION ANALYSIS;
DATA ANALYSIS;
DEPENDENT VARIABLE;
HUMAN;
LUNG FIBROSIS;
MATHEMATICAL ANALYSIS;
MATHEMATICAL MODEL;
METHODOLOGY;
OUTCOME ASSESSMENT;
POWER ANALYSIS;
PRIORITY JOURNAL;
RATING SCALE;
SAMPLE SIZE;
SCHIZOPHRENIA;
STATISTICAL ANALYSIS;
STATISTICAL SIGNIFICANCE;
UNIVARIATE ANALYSIS;
|
EID: 51049124005
PISSN: 00928615
EISSN: None
Source Type: Journal
DOI: 10.1177/009286150804200202 Document Type: Article |
Times cited : (2)
|
References (11)
|